Immunotherapy Study for Surgically Resected Pancreatic Cancer.
Biological: HyperAcute-Pancreas Immunotherapy.
What Is EPCLUSAÂ® (sofosbuvir 400 mg/velpatasvir 100 mg) tablets.
The purpose of this study is to evaluate whether treatment with Epclusa (Sofosbuvir+Velpatasvir) after lung transplantation in individuals with chronic-hepatitis-C infection is feasible, safe and effective at curing HCV using Epclusa.